An estimated 85% of positive Covid-19 test samples in New York City have contained the BA.2 Omicron subvariant.
Subscribe to:
Post Comments (Atom)
< + > Testing the Future of Healthcare Wearables
The following is a guest article by Marie Hattar, SVP at Keysight Technologies Wearable devices are transforming healthcare through contin...
No comments:
Post a Comment